OTCMKTS:LHDXQ Lucira Health (LHDXQ) Stock Price, News & Analysis $0.0001 +0.00 (+∞) As of 10/4/2023 Add Compare Share Share Stock Analysis Stock Analysis About Lucira Health Stock (OTCMKTS:LHDXQ) Get Lucira Health alerts:Sign Up Key Stats Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.00▼$1.45Volume20,900 shsAverage Volume7.18 million shsMarket Capitalization$4.06 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Lucira Health, Inc. was a molecular diagnostics company focused on developing rapid, at-home testing products. The company’s technology was designed to detect respiratory infections using molecular nucleic acid amplification testing, providing results without requiring samples to be sent to a laboratory. Lucira’s principal product was the Lucira COVID-19 All-In-One Test Kit, an authorized over-the-counter molecular test that used a nasal swab and battery-powered testing device to deliver results at home. The company also developed the Lucira Complete COVID-19 & Flu Test, intended to detect influenza A, influenza B and COVID-19 from a single nasal swab. Its products were primarily aimed at consumers, healthcare providers and other organizations in the United States. Lucira Health filed for Chapter 11 bankruptcy protection in 2023 after experiencing financial difficulties. Pfizer subsequently acquired certain assets of the company through the bankruptcy process, including rights related to its molecular testing technology and products. As a result, Lucira Health’s operations and product availability may differ substantially from the period when it operated as an independent diagnostics company.AI Generated. May Contain Errors. Read More Receive LHDXQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lucira Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LHDXQ Stock News HeadlinesHealthcare bankruptcies slow after peaking in 2023: reportAugust 24, 2024 | msn.comU.S. govt. to restart program to ship free at-home COVID testsSeptember 20, 2023 | msn.comElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He points to a new AI project tied to Musk's Cybercab reveal. Brown says Musk has opened major investment windows before, with PayPal, Tesla, and SpaceX marking milestones in tech history. He believes a fourth may open by October 30.October 16 at 1:00 AM | Brownstone Research (Ad)Best Senior Dating Sites Of 2023August 3, 2023 | forbes.comRemember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via Winning Auction BidApril 28, 2023 | benzinga.com8-K: Lucira Health, Inc.April 20, 2023 | marketwatch.comBankruptcy court bidder for Covid-flu test maker Lucira objects to planned sale to PfizerApril 11, 2023 | bizjournals.comPfizer to buy Covid-flu test developer Lucira Health out of bankruptcy courtApril 7, 2023 | bizjournals.comSee More Headlines LHDXQ Stock Analysis - Frequently Asked Questions How have LHDXQ shares performed this year? Lucira Health's stock was trading at $0.0001 at the start of the year. Since then, LHDXQ shares have increased by 0.0% and is now trading at $0.0001. How were Lucira Health's earnings last quarter? Lucira Health, Inc. (OTCMKTS:LHDXQ) announced its quarterly earnings results on Thursday, November, 11th. The company reported ($0.47) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.51) by $0.04. The business earned $14.98 million during the quarter, compared to the consensus estimate of $18 million. What other stocks do shareholders of Lucira Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Lucira Health investors own include Tesla (TSLA), Viking Therapeutics (VKTX), Virgin Galactic (SPCE), American Battery Technology (ABML), Ford Motor (F), General Motors (GM) and Advanced Micro Devices (AMD). Company Calendar Last Earnings11/11/2021Today10/16/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Diagnostic substances Sub-IndustryN/A Current SymbolOTCMKTS:LHDXQ CIK1652724 Webwww.lucirahealth.com Phone510-350-8071FaxN/AEmployees221Year Founded2013Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$93.06 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$4.81 per share Price / Book0.00Miscellaneous Outstanding Shares40,600,000Free Float28,257,000Market Cap$4.06 thousand OptionableNot Optionable Beta2.60 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:LHDXQ) was last updated on 10/4/2023 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredDid you grab your copy yet?Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarte...Profits Run | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucira Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucira Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
